Quantitative assessment of serum hepatitis B e antigen, IgM hepatitis B core antibody and HBV DNA in monitoring the response to treatment in patients with chronic hepatitis B

Journal of Viral Hepatitis

Volumn 4, Issue 4, 1997, Pages 265-272

  Bernard, E ^a   Raymond, G ^a   Willems, B ^a   Villeneuve, J P ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

DNA; HBeAg; HBV; Hepatitis B

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M; VIRUS DNA;

ARTICLE; BLOOD; CHRONIC DISEASE; ENZYME IMMUNOASSAY; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PREDICTION AND FORECASTING; STATISTICAL MODEL;

ALANINE TRANSAMINASE; CHRONIC DISEASE; DNA, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M; INTERFERON ALFA-2B; LOGISTIC MODELS; PREDICTIVE VALUE OF TESTS;

EID: 0031183753     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00055.x     Document Type: Article

References (14)

1. Hoofnagle JH, Peters M, Mullen KD et al. Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318-1325.
2. Brook MG, Karayiannis P, Thomas HC. Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors. Hepatology 1989; 10: 761-763.
3. Perillo RP, Schiff ER, Davis GL et al. A randomized, controlled trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295-301.
4. Perillo RP, Regenstein FG, Peters MG et al. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis: a randomized controlled trial. Ann Intern Med 1988; 109: 95-100.
5. Dienstag JL, Perillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657-1661.
6. Villeneuve JP, Willems B. Treatment of chronic hepatitis B with interferon: long-term follow-up. Can J Gastroenterol 1996; 10: 21-25.
7. Perillo R, Mimms L, Schechtman K, Robbins D, Campbell C. Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV-DNA testing. Hepatology 1993; 18: 1306-1312.
8. Brunetto MR, Cerenzia MT, Oliveri F et al. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 1993; 19: 431-436.
9. Marinos G, Smith HM, Naoumov NV, Williams R. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection. Hepatology 1994; 19: 303-311.
10. Eble K, Clemens J, Krenc C et al. Differential diagnosis of acute viral hepatitis using rapid fully automated immunoassays. J Med Virol 1991; 33: 139-150.
11. Kuhns MC, McNamara AL, Perillo RP, Cabal CM, Campbell CR. Quantification of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy. J Med Virol 1989; 27: 274-281.
12. Wong DHK, Chung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A metaanalysis. Ann Intern Med 1993; 119: 312-323.
13. Kruger M, Tillman HL, Trautwein C et al. Famciclovir treatment of hepatitis B recurrence after liver transplantation: a pilot study. Liver Transpl Surg 1996; 2: 253-262.
14. Butterworth LA, Prior SL, Buda PJ, Faoagali JL, Cooksley WGE. Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J Hepatol 1996; 24: 686-691.